tetano
Editor, Senior Moderator
Respirology. 2019 Jun 21. doi: 10.1111/resp.13629. [Epub ahead of print]
[h=1]Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection.[/h] Laghlali G[SUP]1,[/SUP][SUP]2[/SUP], Tate MD[SUP]1,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h]
[h=4]KEYWORDS:[/h] immunopathology; influenza virus; therapies
PMID: 31225681 DOI: 10.1111/resp.13629
[h=1]Targeting endosomal NOX2 as a potential therapy to limit influenza A virus infection.[/h] Laghlali G[SUP]1,[/SUP][SUP]2[/SUP], Tate MD[SUP]1,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h]
[h=4]KEYWORDS:[/h] immunopathology; influenza virus; therapies
PMID: 31225681 DOI: 10.1111/resp.13629